In 4-nitroquinoline-induced mouse HNSCC, cancer stem cells (CSCs) use the immune checkpoint molecule CD276 (B7-H3) to evade immune surveillance (Elmusrati et al., 2021). Here, CD276 is linked to head and neck squamous cell carcinoma.